Found 0 matching trials
Monthly And Twice Monthly Subcutaneous Dosing Of PF-04950615 (RN316) In Hypercholesterolemic Subjects On A Statin
PHASE2To evaluate the Low Density Lipoprotein-Cholesterol (LDL-C) lowering effect...
Location
Achieve Clinical Research, LLC
A Multiple Dose Study of PF-04950615 (RN316) in Subjects on High Doses of Statins
PHASE2This study will investigate the effect of PF-04950615, a new investigationa...
Location
Orange County Research Center
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
PHASE3This study is a multicenter, randomized study in subjects with high cholest...
Location
Achieve Clinical Research, LLC
Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia
PHASE1The primary objective of this study is to evaluate the safety and tolerabil...
Location
California Clinical Trials Medical Group
A Pharmacokinetic and Pharmacodynamic Study of PF-04950615 (RN316) in Subjects With Hypercholesterolemia
PHASE1This Phase 1 study has been designed to evaluate the absolute bioavailabili...
Location
Profil Institute for Clinical Research, Inc.
A Multiple Dose Study Of PF-04950615 (RN316) In Subjects On Maximum Doses Of Statins
PHASE2PF-04950615 is a new investigational hypercholesterolemic agent that is bei...
Location
Achieve Clinical Research, LLC
Dose Ranging Study Of Bococizumab (PF-04950615; RN316) In Hypercholesterolemic Japanese Subjects
PHASE2The purpose of this study is to evaluate the low density lipoprotein choles...
Location
Maebashi Hirosegawa Clinic
Multiple-Dose Safety Study Of RN316 For TheTreatment Of Hypercholesterolemia
PHASE1The primary objective of this study is to evaluate the safety and tolerabil...
Location
Multiple Locations
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins
PHASE3This study is a multicenter, double blinded, active and placebo controlled ...
Location
Creekside Endocrine Associates, PC